Tenderwize
Retour à la recherche

Open house Doravirin discount agreements

AOK Bayern - Die Gesundheitskasse·München, Germany·Deadline Apr 03, 2028 · 583 days left·Open·Supplies·Framework
Inscrivez-vous pour sauvegarderOpen documents
Structured notice only
Titre original de l'avis

Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Doravirin, ATC J05AG06

50/100

Score d'opportunité

Needs reviewLow complexity
SuppliesFrameworkOpen
Pourquoi ce score ?

Opportunité

50 / 100

Complexité

20 / 100

Facteurs de risque

No estimated value or framework maximum value is provided. The commercial opportunity cannot be quantified.

Open-house agreements automatically expire if a traditional procurement discount contract (federal or state level) is s...

Analyse approfondie du portefeuille

Analyse approfondie de l'adéquation entreprise

Utilise:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Aperçu

Moderate opportunity

Faits clés

  • Framework procurement
  • Supplies contract
  • 1 lot
  • Duration until May 2028
  • Supply of Doravirin (ATC J05AG06) pharmaceutical products
  • Non-exclusive discount agreements with AOK Bayern
Afficher le résumé complet

Open-house model (non-exclusive) for discount agreements on the active substance Doravirin (ATC J05AG06) with AOK Bayern. All eligible pharmaceutical companies can join identical, non-negotiable contracts for the period 01.06.2026 to 31.05.2028. No estimated value provided. No formal award criteria since no selection takes place. Submission via signed declaration of reliability; physical or electronic with qualified signature accepted. Contracts can be concluded at any time until 03.04.2028.

Risques

No estimated value or framework maximum value is provided. The commercial opportunity cannot be quantified.

Open-house agreements automatically expire if a traditional procurement discount contract (federal or state level) is s...

L'analyse peut être incomplète

Seule une partie des documents de consultation a été analysée. Des exigences, certificats ou documents de soumission supplémentaires peuvent exister dans les documents restants.

Exigences clés

Certifications

  • Eligibility: signed declaration of reliability (self-certification form)
  • Language: documents must be in German or accompanied by a certified German translation

Administrative

  • Submission: physical (2 copies original, hand-signed) or electronic (qualified electronic signature) via DTVP portal

Les exigences peuvent être incomplètes.

Critères d'attribution

Lot 1

No award criteria – open-house model, no selection among participants.

Acheteur

Localisation

München, DEU

Site web

www.aok.de

Profil acheteur

Ouvrir le profil

Identifiant

DE811695320

Activité

Health

Lots (1)

LOT-0001

Open house Doravirin discount agreements

Non-exclusive discount agreements for Doravirin (ATC J05AG06) with AOK Bayern. Contracts run from 01.06.2026 to 31.05.2028. Open to all pharmaceutical companies meeting eligibility. No selection – all who apply and meet criteria get a contract. Submission deadline: contracts can be signed until 03.04.2028 (monthly cut-off dates apply for start dates).

SuppliesFrameworkEU fundedElectronic submission

Localisation

DE212, Germany

Durée

May 2026 - May 2028

Catégorie

Pharmaceutical products

Critères d'attribution

No award criteria – open-house model, no selection among participants.

Date limite

Deadline Apr 03, 2028

Détails de la procédure

Date de publication
14 Apr 2026
Langues
German

Métadonnées de référence

Base juridique
32014L0024

Identifiants de référence

ID de l'appel d'offres
257844-2026

Documents (2)

Document de consultation 1Portail de soumission 1

Appels d'offres similaires

Bulgaria – Pharmaceutical products – Динамична система за покупки за доставка на лекарствени продукти за Медицински институт на МВР

Jul 9

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Oralair(R) (ATC-Code nach WHO: V01AA02)

Aug 31

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Ipratropiumbromid (ATC-Code nach WHO: R03BB01)

Sep 30

Denmark – Pharmaceutical products – Amgros 2027 1.1170.a

Sep 3

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Orylmyte(R) (ATC-Code nach WHO: V01AA03)

Aug 31

Germany – Pharmaceutical products – Open House Biologika Rabattverträge 2026 - 27 - Follitropin delta

Aug 30